{"id":1138,"date":"2026-07-06T15:21:21","date_gmt":"2026-07-06T19:21:21","guid":{"rendered":"https:\/\/www.celystrapharma.com\/?page_id=1138"},"modified":"2026-07-06T17:15:20","modified_gmt":"2026-07-06T21:15:20","slug":"board-of-directors","status":"publish","type":"page","link":"https:\/\/www.celystrapharma.com\/en\/board-of-directors\/","title":{"rendered":"Board of Directors"},"content":{"rendered":"\n
\n
\n

About Us : the Board of Directors<\/strong><\/p>\n\n\n\n

A team of experienced professionals serving CELYSTRA Pharma’s governance<\/h1>\n\n\n\n

Our Board of Directors brings together experienced individuals, including Paul L\u00e9vesque, our President, as well as members from our investment partners.<\/p>\n<\/div>\n<\/section>\n\n

\n

Board Members<\/h2>\n\n\n\n
\n

Louis-\u00c9tienne Fortier<\/h3>\n\n\n\n

Managing director, Investments \u2013 Life Sciences, Investissement Qu\u00e9bec<\/p>\n\n\n\n

Louis-\u00c9tienne Fortier serves on the Board of Directors of Celystra Pharma and is Managing Director, Investments, Life Sciences at Investissement Qu\u00e9bec, the province\u2019s leading economic development and investment agency. With nearly 20 years of experience in finance, including more than a decade in private equity and growth investing, he oversees a portfolio spanning biotechnology, medical technology, specialty pharmaceuticals, and life sciences services. <\/p>\n\n\n\n

Throughout his career, Mr. Fortier has held leadership positions in investment management, corporate finance, and financial advisory. He also serves on multiple boards and advisory committees, providing strategic guidance, governance oversight, and support for long-term value creation. <\/p>\n\n\n\n

Mr. Fortier holds a Bachelor of Business Administration in Accounting from the Universit\u00e9 de Sherbrooke and is a Chartered Professional Accountant (CPA). <\/p>\n<\/div>\n\n\n\n

\n

Sean Karamchandani<\/h3>\n\n\n\n

Principal, Credit Mutuel Equity<\/p>\n\n\n\n

Sean Karamchandani is Investment Principal in the Canadian venture capital arm of Cr\u00e9dit Mutuel Equity, a private equity subsidiary of Cr\u00e9dit Mutuel Alliance F\u00e9d\u00e9rale, one of France\u2019s largest banking organizations.<\/p>\n\n\n\n

With 10 years of experience in healthcare investment in both venture and growth-equity Sean began his career as a management consultant to large healthcare institutions. He was then a partner with Persistence Capital Partners, a Canadian healthcare focused private-equity fund. Sean has dedicated his career to accelerating healthcare service, device, product, and pharmaceutical companies. <\/p>\n\n\n\n

Sean holds a bachelor\u2019s degree in economics from Harvard University and an MBA from Columbia Business School in New York. <\/p>\n<\/div>\n\n\n\n

\n

Paul L\u00e9vesque<\/h3>\n\n\n\n

President, Chief Executive Officer & Co-founder<\/p>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Paul brings more than 40 years of experience in the research-based pharmaceutical industry. Before co-founding Celystra Paul served as President and CEO of Theratechnologies Inc. from 2020 to 2025. <\/p>\n\n\n\n

\n
See his profile<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n

Marc-Olivier Sirard<\/h3>\n\n\n\n

Director, Private Equity and Impact Investing \u2013 Life Sciences, Fonds de solidarit\u00e9 FTQ <\/p>\n\n\n\n

Working in the Venture Capital for more than 10 years, Marc-Olivier is involved in many life science companies, from preclinical to commercial stage, as well as in venture capital funds. <\/p>\n\n\n\n

Marc-Olivier holds a CPA, CA designation from the Ordre des Comptables Professionnels Agr\u00e9\u00e9s du Qu\u00e9bec. <\/p>\n<\/div>\n<\/section>\n\n

\n

Partnerships<\/p>\n\n\n\n

Accelerating access to patients.<\/h2>\n\n\n\n

We bring the know-how to effectively navigate partnered medicines through regulatory approval and Canada\u2019s complex market access environment with a focus on commercial availability.<\/p>\n\n\n\n

\n
Become a partner<\/a><\/div>\n\n\n\n
Start the conversation<\/a><\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

About Us : the Board of Directors A team of experienced professionals serving CELYSTRA Pharma’s governance Our Board of Directors brings together experienced individuals, including Paul L\u00e9vesque, our President, as well as members from our investment partners. Board Members Louis-\u00c9tienne Fortier Managing director, Investments \u2013 Life Sciences, Investissement Qu\u00e9bec Louis-\u00c9tienne Fortier serves on the Board […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_page_bg_type":"none","_page_bg_color":"","_page_bg_image_url":"","_page_bg_image_size":"cover","_page_bg_image_position":"center center","_page_bg_image_repeat":"no-repeat","_page_bg_image_fixed":false,"footnotes":""},"class_list":["post-1138","page","type-page","status-publish","hentry"],"yoast_head":"\nBoard of Directors | Celystra Pharma<\/title>\n<meta name=\"description\" content=\"Our Board of Directors brings together experienced individuals, including Paul L\u00e9vesque, our President, as well as members from our investment partners.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.celystrapharma.com\/en\/board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Board of Directors | Celystra Pharma\" \/>\n<meta property=\"og:description\" content=\"Our Board of Directors brings together experienced individuals, including Paul L\u00e9vesque, our President, as well as members from our investment partners.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.celystrapharma.com\/en\/board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Celystra Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-06T21:15:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.celystrapharma.com\/wp-content\/uploads\/2026\/07\/celystra-pharma-FB-social-media-1-1024x640.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/board-of-directors\\\/\",\"name\":\"Board of Directors | Celystra Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.celystrapharma.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Paul_Levesque-Celystra-Launch-2026.jpg\",\"datePublished\":\"2026-07-06T19:21:21+00:00\",\"dateModified\":\"2026-07-06T21:15:20+00:00\",\"description\":\"Our Board of Directors brings together experienced individuals, including Paul L\u00e9vesque, our President, as well as members from our investment partners.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.celystrapharma.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Paul_Levesque-Celystra-Launch-2026.jpg\",\"contentUrl\":\"https:\\\/\\\/www.celystrapharma.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Paul_Levesque-Celystra-Launch-2026.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/\",\"name\":\"Celystra Pharma\",\"description\":\"Illuminating life at the cellular level\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/#organization\",\"name\":\"Celystra Pharma\",\"url\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.celystrapharma.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/logo-celystrapharma-horizontal.svg\",\"contentUrl\":\"https:\\\/\\\/www.celystrapharma.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/logo-celystrapharma-horizontal.svg\",\"width\":290,\"height\":46,\"caption\":\"Celystra Pharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.celystrapharma.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/celystrapharma\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Board of Directors | Celystra Pharma","description":"Our Board of Directors brings together experienced individuals, including Paul L\u00e9vesque, our President, as well as members from our investment partners.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.celystrapharma.com\/en\/board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Board of Directors | Celystra Pharma","og_description":"Our Board of Directors brings together experienced individuals, including Paul L\u00e9vesque, our President, as well as members from our investment partners.","og_url":"https:\/\/www.celystrapharma.com\/en\/board-of-directors\/","og_site_name":"Celystra Pharma","article_modified_time":"2026-07-06T21:15:20+00:00","og_image":[{"url":"https:\/\/www.celystrapharma.com\/wp-content\/uploads\/2026\/07\/celystra-pharma-FB-social-media-1-1024x640.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.celystrapharma.com\/en\/board-of-directors\/","url":"https:\/\/www.celystrapharma.com\/en\/board-of-directors\/","name":"Board of Directors | Celystra Pharma","isPartOf":{"@id":"https:\/\/www.celystrapharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.celystrapharma.com\/en\/board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.celystrapharma.com\/en\/board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.celystrapharma.com\/wp-content\/uploads\/2026\/03\/Paul_Levesque-Celystra-Launch-2026.jpg","datePublished":"2026-07-06T19:21:21+00:00","dateModified":"2026-07-06T21:15:20+00:00","description":"Our Board of Directors brings together experienced individuals, including Paul L\u00e9vesque, our President, as well as members from our investment partners.","breadcrumb":{"@id":"https:\/\/www.celystrapharma.com\/en\/board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.celystrapharma.com\/en\/board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.celystrapharma.com\/en\/board-of-directors\/#primaryimage","url":"https:\/\/www.celystrapharma.com\/wp-content\/uploads\/2026\/03\/Paul_Levesque-Celystra-Launch-2026.jpg","contentUrl":"https:\/\/www.celystrapharma.com\/wp-content\/uploads\/2026\/03\/Paul_Levesque-Celystra-Launch-2026.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.celystrapharma.com\/en\/board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.celystrapharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.celystrapharma.com\/en\/#website","url":"https:\/\/www.celystrapharma.com\/en\/","name":"Celystra Pharma","description":"Illuminating life at the cellular level","publisher":{"@id":"https:\/\/www.celystrapharma.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.celystrapharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.celystrapharma.com\/en\/#organization","name":"Celystra Pharma","url":"https:\/\/www.celystrapharma.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.celystrapharma.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.celystrapharma.com\/wp-content\/uploads\/2026\/06\/logo-celystrapharma-horizontal.svg","contentUrl":"https:\/\/www.celystrapharma.com\/wp-content\/uploads\/2026\/06\/logo-celystrapharma-horizontal.svg","width":290,"height":46,"caption":"Celystra Pharma"},"image":{"@id":"https:\/\/www.celystrapharma.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/celystrapharma\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.celystrapharma.com\/en\/wp-json\/wp\/v2\/pages\/1138","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.celystrapharma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.celystrapharma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.celystrapharma.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.celystrapharma.com\/en\/wp-json\/wp\/v2\/comments?post=1138"}],"version-history":[{"count":4,"href":"https:\/\/www.celystrapharma.com\/en\/wp-json\/wp\/v2\/pages\/1138\/revisions"}],"predecessor-version":[{"id":1164,"href":"https:\/\/www.celystrapharma.com\/en\/wp-json\/wp\/v2\/pages\/1138\/revisions\/1164"}],"wp:attachment":[{"href":"https:\/\/www.celystrapharma.com\/en\/wp-json\/wp\/v2\/media?parent=1138"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}